• FirefoxInstall the new Firefox »
  •  Dow Down 0.58% Nasdaq Down 0.26%

    DepoMed Inc. (DEPO)

    -NasdaqGS
    23.65 Up 0.66(2.85%) 4:00PM EST
    |After Hours : 23.65 Up 0.00 (0.02%) 5:10PM EST
    Add to Portfolio
    Prev Close:22.99
    Open:22.89
    Bid:23.65 x 200
    Ask:24.88 x 300
    1y Target Est:23.40
    Beta:1.67
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:22.51 - 23.78
    52wk Range:9.85 - 23.78
    Volume:1,442,627
    Avg Vol (3m):1,148,410
    Market Cap:1.41B
    P/E (ttm):11.53
    EPS (ttm):2.05
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    DEPOUp 2.85%1.41B
    MRKDown 0.79%164.27B
    PFEUp 0.23%212.30B
    TEVAUp 0.18%48.18B

    Key Statistics

    Forward P/E (1 yr):26.27
    P/S (ttm):3.51
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.39
    Quarterly EPS Est (Mar-15) :0.01
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):1.97

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Depomed, Inc., a specialty pharmaceutical company, develops products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the management of postherpetic neuralgia; CAM... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback